Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases

NCT03676257 · clinicaltrials.gov ↗

COMPLETED

Status

20033

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Chemotherapy (exclusive)
DRUG: Endocrine therapy (exclusive)
DRUG: Combination of endocrine therapy and chemotherapy
DRUG: Chemotherapy and targeted treatment
DRUG: Combination of endocrine therapy and targeted treatment
DRUG: Combination of chemotherapy, endocrine therapy and targeted treatment

Sponsor

Institut Bergonié

Collaborators

[object Object]
[object Object]